Trials / Sponsors / Qu Biologics Inc.
Qu Biologics Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tra Immune Deficiency | Phase 2 | 2023-04-11 |
| Terminated | QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease Crohn Disease | Phase 2 | 2018-06-25 |
| Withdrawn | Single and Multiple Dose Evaluation of QBKPN SSI In Healthy Volunteers Healthy | Phase 1 | 2016-09-01 |
| Completed | Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2015-07-01 |
| Completed | Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2014-12-01 |
| Completed | Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease Crohn's Disease, Inflammatory Bowel Disease | Phase 1 / Phase 2 | 2013-03-01 |